It is a great pleasure and honor to announce that the Department of Uro-Oncology, RGCIRC, New Delhi, will be hosting the 20th Annual conference – RGCON 2022. This event shall be held at the Crowne Plaza Hotel, Rohini, New Delhi on 15th, 16th and 17th April, 2022.
The conference is designed to provide attendees with an in-depth, multidisciplinary analysis of the timeliest topics in the diagnosis, treatment, and study of GU malignancies. All members of the cancer care and research community will benefit from the conference exploration of the latest science in the field and its clinical application.
With more basic research, real-world clinical practice patterns, and in-depth discussions of data, virtually it will help to expand the knowledge and explore the latest in Oncology science for all the participants.
The scientific program includes workshop, lectures, and panel discussions & has been designed to include diagnostic as well as therapeutic Uro- Oncology.
We have invited renowned national and international faculty in the field of Uro-Oncology to share their views & deliver lectures on the current state of the art practices.
We have kept abstract presentations by young oncologists & have kept exciting prizes for the winner. We request you to encourage your, residents, and fellow with interest in Uro-Oncology, to participate in this meeting.
The conference will provide excellent opportunity to interact with stalwart, build consensus & forge new avenues of collaboration.
We look forward to welcoming you to this conference.
Yours sincerely,
Dr Sudhir Rawal
Program Director – RGCON 2022
Medical Director Chief urogenital oncology
Rajiv Gandhi Cancer Institute, Delhi
Director – Medical Oncology
Rajiv Gandhi Cancer Institute, Delhi
Director – Radiation Oncology
Rajiv Gandhi Cancer Institute, Delhi
Consultant, Dept. of GenitoUro-Oncology
Rajiv Gandhi Cancer Institute, Delhi
Consultant, Dept. of GenitoUro-Oncology
Rajiv Gandhi Cancer Institute, Delhi
Rajiv Gandhi Cancer Institute, Delhi
Medical Director Chief urogenital oncology
+91 9810139757
Rajiv Gandhi Cancer Institute, Delhi
Director – Medical Oncology
+91 9810241512
Rajiv Gandhi Cancer Institute, Delhi
Director – Radiation Oncology
+91 9958431598
Rajiv Gandhi Cancer Institute, Delhi
Consultant, Dept. of GenitoUro-Oncology
+91 9643710442
Rajiv Gandhi Cancer Institute, Delhi
Consultant, Dept. of GenitoUro-Oncology
+91 8727069800
MD, MPH Department of Radiation Oncology University of Virginia VP of Clinical Development
(MD, MBA, FASTRO and FABS) Academic chief Allegheny Health Network Pittsburgh. PA
Chair and Honorary Consultant in Clinical Oncology The Christie NHS Foundation Trust Wilmslow Road United Kingdom
Associate physician at Taussig cancer centre, Cleveland clinic, Ohio Associate professor, Lerner college of medicine of Case Western Reserve University
MD Associate Professor Chief of Genitourinary Oncology Service Vice Chair of Clinical and Translational Research Department of Radiation Oncology University of California, Los Angeles
Chair of urology, consultant urological surgeon Imperial College Healthcare NHS Trust London
Director of Urology Department Niguarda Ca ‘Granda Hospital, Milan
MD, FACS Chief, Urology Service; Peter T. Scardino Chair in Oncology, Memorial Sloan Kettering Cancer Center, New York
MD Professor of Clinical Urology Vice Chair, New Technology & Innovation Director, Center for Advanced Robotics Health Sciences Campus Los Angeles
Department of Urology, AIIMS, New Delhi
MD., MSc. Director, Al Hyatt Oncology Practice Adjunct Professor of Medical Oncology Past President of Jordanian Oncology Society
Deputy Chair and Senior Consultant, Division of Medical Oncology, National Cancer Centre Singapore Associate Professor, Duke-NUS Medical School, Singapore
Professor of Medicine (Oncology) and by courtesy, of Urology Medical oncologist, Urologic specialist, Genitourinary specialist Stanford University School of Medicine, Stanford
MD Head of the Medical Oncology, Anderson Cancer Center, Madrid
Senior Consultant Surgical Oncologist JDWNR Hospital Thimphu, Professor General Surgery Khesar Gyalpo University of Medical Science Thimphu: Bhutan Bhutan Cancer Society – Executive Board Member
Sr. Consultant Clinical Oncologist Norvic International Hospital and Om Hospital & Research Center, Kathmandu, Nepal Immediate Past Chairman: SAARC Federation Of Oncologist (SFO) Chairman: SAARC Federation Of Oncologist – Nepal (SFON)
Consultant Uro-Oncologic Surgeon, Department of Surgical Oncology Nepal Cancer Hospital and Research Center (NCHRC)
Founder & Executive Chairman Sr. Consultant Medical Oncologist Nepal Cancer Hospital and Research Center
Theme: “Live Operative Workshop Surgical : Learning from the legends”
15th April 2022
Registration
Session 1 – Uro Oncologic Surgery – Basics
MP MRI for Prostate Cancer – Surgeon’s Perspective
3D Model Reconstruction in Uro-Oncology : HYPE or HOPE
Live Operative Session – Retzius Sparing Robotic Radical Prostatectomy
Quiz
Welcome Speech
Opening Remarks
Newer Age Genomics In Prostate Cancer : Impact On Practice In Daily Radiation Oncology Clinics
Brachytherapy Session
Expert Comment
Tea Break
Dr K K Pandey Oration : Focussing On A Subspecialty : Is It The Way Forward
Lunch
Panel Discussion – Case Based Discussion (High And Very High Risk Prostate Cancer )
Panel Discussion – EBRT Contouring Dilemmas
Nursing Conclave
Residents Bowl : Quiz
Genomic And Genetic Testing For Prostate Cancer:Basics/Indications/Implications And Future Directions
MP MRI For Diagnosis /Fusion Biopsy Techniques And Latest Advances
Psma Pet Imaging In Prostate Cancer : Guiding Clinical Management
MR – Fusion transperineal vs transrectal biopsy
How to shorten the learning curveof RS RALP (TO Achiece the TRIFECTA OUTCOMES)
Debate : Debate Focal Therapy Vs Radical Prostatectomy For Localised Prostate Cancer , Low Volume, Intermediate Risk
Focal therapy – Indications,Techniques and Future advancement
Debate : Radical Prostatectomy Vs Rt For Locally Advanced Prostate Cancer
Evolving Landscape In The Treatment Of HSPC
Panel discussion on mHSPC Double vs Triple
Treatment Sequencing And Recent Advances In Crpc
Theranostics In Prostate Cancer : Current Evidence And Future Directions
Panel discussion on CRPC
Robotic Nephroureterectomy Lymphnode dissection with bladder cuff excision inching towards standard of care in realms of MIS
Use of DaVinci Sp in Extra Peritoneal RALP and Transvesical RALP
Lunch Break
Dr Raman Chadha Oration : AI In Genitourinary Oncology
Molecular Subtyping In Bladder Cancer : Integrating With Clinical Practice
Variant Pathology In Bladder Cancer : Clinical Implication
Virads In Bladder Cancer : Current Applications And Future Development (Radiomics)
Bcg Unresponsive Bladder Cancer : Definition , Treatment Options And Future Directions
Debate : Nact Vs Adjuvant Chemotherapy
Debate On Tmt Vs Rc In MIBC
Role Of RT As Adjuvant Treatment Following Rc For Locally Advanced Bladder Cancer
Neoadjuvant And Adjuvant Immunotherapy For Locally Advanced Bladder Cancer
Changing Paradigms In The Treatment Of Metastatic Bladder Cancer
Panel Discussion – Locally Advanced and Metastatic Bladder Cancer
New paradigm in the management of advanced urothelial carcinoma
Ethics and Trial
Innaugral Function
Live surgical session – Robotic partial nephrectomy- retroperitoneal approach
New Biomarkers In RCC( Molecular Aspect) – Oncologist Perspective
Newer Imaging Advances In Kidney Cancer Management (Ceus , Dual Energy Ct, Mpmri, Pet Scan, Spect, Radiomics)
Maximising Pentafecta Outcomes Following Nss : Tools And Techniques
Debate : Focal Therapy Vs NSS For Small Renal Mass
Surgical Management In Locally Advanced Renal Cell Cancer
Neoadjuvant And Adjuvant Tretament Strategies For Locally Advanced Renal Cell Carcinoma (Include Ivc Thrombus , Solitary Kindey Masses , Bilateral Renal Masses , Sarcomatoid Rcc )
Response Assessment Following Immunotherapy (When To Do , How To Interpret , Pseudoprogression)
Mr. KK Mehta Oration : Optimal Selection Of Patients With Untreated Mrcc For Combination And Monotherpay Regimens
Cytoreductive Nephrectomy : Indications , Timing And Evidences In Current Tki/Io Era
2nd Line And Beyond In Mrcc: Panel Discussion
Top 5 Oral Abstracts
Valedictory Function
Lunch
Chief urogenital oncology
Medical Director
Rajiv Gandhi Cancer Institute, Delhi +91 9810139757
Director – Medical Oncology
Rajiv Gandhi Cancer Institute, Delhi +91 9810241512
Director – Radiation Oncology
Rajiv Gandhi Cancer Institute, Delhi +91 9958431598
Consultant, Dept. of GenitoUro-Oncology
Rajiv Gandhi Cancer Institute, Delhi +91 9643710442
Consultant, Dept. of GenitoUro-Oncology
Rajiv Gandhi Cancer Institute, Delhi +91 8727069800
As a society, RGCIRC is looking forward to get support from generous people
Read More
It is a fact that there are absolutely no substitutes to replace human bloo...
Read More
Volunteers play an important role in today’s hospitals. They help the hos...
Read MoreRajiv Gandhi Cancer Institute & Research Centre is today counted amongst Asia’s premier exclusive cancer centres that offer unique advantage of cutting edge technology, put to use by renowned super specialists. This potent combination of man and machine ensures world-class cancer care to not only patients from India, but also from the neighboring SAARC countries and others.
D - 18, Sector - 5, Rohini, Delhi - 110085 | +91-11-47022222 OPD Timings: 09:00 am to 05:00 pm (All weekdays except Sunday and Holiday) Emergency Services: 24x7 All weekdays
Mahendra Kumar Jain Marg, Niti Bagh, New Delhi - 110049 | Tel: +91-11-45822222 / 2200 OPD Timings: 09:00 am to 05:00 pm (All Weekdays except Sunday and Holiday) Emergency Services: 24x7 All Weekdays